Bendamustine Market - Global Outlook and Forecast 2022-2028

January 2022 | 73 pages | ID: B8968A9CC691EN
Market Monitor Global

Abstracts

Bendamustine is a chemotherapy medication used in the treatment of chronic lymphocytic leukemia (CLL), multiple myeloma, and non-Hodgkin's lymphoma. It is given by injection into a vein.

This report contains market size and forecasts of Bendamustine in global, including the following market information:

Global Bendamustine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Bendamustine Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Bendamustine companies in 2021 (%)

The global Bendamustine market was valued at 815.2 million in 2021 and is projected to reach US$ 767.3 million by 2028, at a CAGR of -0.9% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

25mg Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Bendamustine include Teva, Eisai, Eagle Pharmaceuticals, MundiPharma, Mylan, Natco Pharma, Emcure and Miracalus Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bendamustine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Bendamustine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Bendamustine Market Segment Percentages, by Type, 2021 (%)

• 25mg Injection
• 100mg Injection
• Others

Global Bendamustine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Bendamustine Market Segment Percentages, by Application, 2021 (%)

• Chronic Lymphocytic Leukemia
• Multiple Myeloma
• Non-Hodgkin's Lymphoma

Global Bendamustine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Bendamustine Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Bendamustine revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Bendamustine revenues share in global market, 2021 (%)

Key companies Bendamustine sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Bendamustine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Teva
• Eisai
• Eagle Pharmaceuticals
• MundiPharma
• Mylan
• Natco Pharma
• Emcure
• Miracalus Pharma

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Bendamustine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Bendamustine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BENDAMUSTINE OVERALL MARKET SIZE

2.1 Global Bendamustine Market Size: 2021 VS 2028
2.2 Global Bendamustine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Bendamustine Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Bendamustine Players in Global Market
3.2 Top Global Bendamustine Companies Ranked by Revenue
3.3 Global Bendamustine Revenue by Companies
3.4 Global Bendamustine Sales by Companies
3.5 Global Bendamustine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Bendamustine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Bendamustine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Bendamustine Players in Global Market
  3.8.1 List of Global Tier 1 Bendamustine Companies
  3.8.2 List of Global Tier 2 and Tier 3 Bendamustine Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Bendamustine Market Size Markets, 2021 & 2028
  4.1.2 25mg Injection
  4.1.3 100mg Injection
  4.1.4 Others
4.2 By Type - Global Bendamustine Revenue & Forecasts
  4.2.1 By Type - Global Bendamustine Revenue, 2017-2022
  4.2.2 By Type - Global Bendamustine Revenue, 2023-2028
  4.2.3 By Type - Global Bendamustine Revenue Market Share, 2017-2028
4.3 By Type - Global Bendamustine Sales & Forecasts
  4.3.1 By Type - Global Bendamustine Sales, 2017-2022
  4.3.2 By Type - Global Bendamustine Sales, 2023-2028
  4.3.3 By Type - Global Bendamustine Sales Market Share, 2017-2028
4.4 By Type - Global Bendamustine Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Bendamustine Market Size, 2021 & 2028
  5.1.2 Chronic Lymphocytic Leukemia
  5.1.3 Multiple Myeloma
  5.1.4 Non-Hodgkin's Lymphoma
5.2 By Application - Global Bendamustine Revenue & Forecasts
  5.2.1 By Application - Global Bendamustine Revenue, 2017-2022
  5.2.2 By Application - Global Bendamustine Revenue, 2023-2028
  5.2.3 By Application - Global Bendamustine Revenue Market Share, 2017-2028
5.3 By Application - Global Bendamustine Sales & Forecasts
  5.3.1 By Application - Global Bendamustine Sales, 2017-2022
  5.3.2 By Application - Global Bendamustine Sales, 2023-2028
  5.3.3 By Application - Global Bendamustine Sales Market Share, 2017-2028
5.4 By Application - Global Bendamustine Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Bendamustine Market Size, 2021 & 2028
6.2 By Region - Global Bendamustine Revenue & Forecasts
  6.2.1 By Region - Global Bendamustine Revenue, 2017-2022
  6.2.2 By Region - Global Bendamustine Revenue, 2023-2028
  6.2.3 By Region - Global Bendamustine Revenue Market Share, 2017-2028
6.3 By Region - Global Bendamustine Sales & Forecasts
  6.3.1 By Region - Global Bendamustine Sales, 2017-2022
  6.3.2 By Region - Global Bendamustine Sales, 2023-2028
  6.3.3 By Region - Global Bendamustine Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Bendamustine Revenue, 2017-2028
  6.4.2 By Country - North America Bendamustine Sales, 2017-2028
  6.4.3 US Bendamustine Market Size, 2017-2028
  6.4.4 Canada Bendamustine Market Size, 2017-2028
  6.4.5 Mexico Bendamustine Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Bendamustine Revenue, 2017-2028
  6.5.2 By Country - Europe Bendamustine Sales, 2017-2028
  6.5.3 Germany Bendamustine Market Size, 2017-2028
  6.5.4 France Bendamustine Market Size, 2017-2028
  6.5.5 U.K. Bendamustine Market Size, 2017-2028
  6.5.6 Italy Bendamustine Market Size, 2017-2028
  6.5.7 Russia Bendamustine Market Size, 2017-2028
  6.5.8 Nordic Countries Bendamustine Market Size, 2017-2028
  6.5.9 Benelux Bendamustine Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Bendamustine Revenue, 2017-2028
  6.6.2 By Region - Asia Bendamustine Sales, 2017-2028
  6.6.3 China Bendamustine Market Size, 2017-2028
  6.6.4 Japan Bendamustine Market Size, 2017-2028
  6.6.5 South Korea Bendamustine Market Size, 2017-2028
  6.6.6 Southeast Asia Bendamustine Market Size, 2017-2028
  6.6.7 India Bendamustine Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Bendamustine Revenue, 2017-2028
  6.7.2 By Country - South America Bendamustine Sales, 2017-2028
  6.7.3 Brazil Bendamustine Market Size, 2017-2028
  6.7.4 Argentina Bendamustine Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Bendamustine Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Bendamustine Sales, 2017-2028
  6.8.3 Turkey Bendamustine Market Size, 2017-2028
  6.8.4 Israel Bendamustine Market Size, 2017-2028
  6.8.5 Saudi Arabia Bendamustine Market Size, 2017-2028
  6.8.6 UAE Bendamustine Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Teva
  7.1.1 Teva Corporate Summary
  7.1.2 Teva Business Overview
  7.1.3 Teva Bendamustine Major Product Offerings
  7.1.4 Teva Bendamustine Sales and Revenue in Global (2017-2022)
  7.1.5 Teva Key News
7.2 Eisai
  7.2.1 Eisai Corporate Summary
  7.2.2 Eisai Business Overview
  7.2.3 Eisai Bendamustine Major Product Offerings
  7.2.4 Eisai Bendamustine Sales and Revenue in Global (2017-2022)
  7.2.5 Eisai Key News
7.3 Eagle Pharmaceuticals
  7.3.1 Eagle Pharmaceuticals Corporate Summary
  7.3.2 Eagle Pharmaceuticals Business Overview
  7.3.3 Eagle Pharmaceuticals Bendamustine Major Product Offerings
  7.3.4 Eagle Pharmaceuticals Bendamustine Sales and Revenue in Global (2017-2022)
  7.3.5 Eagle Pharmaceuticals Key News
7.4 MundiPharma
  7.4.1 MundiPharma Corporate Summary
  7.4.2 MundiPharma Business Overview
  7.4.3 MundiPharma Bendamustine Major Product Offerings
  7.4.4 MundiPharma Bendamustine Sales and Revenue in Global (2017-2022)
  7.4.5 MundiPharma Key News
7.5 Mylan
  7.5.1 Mylan Corporate Summary
  7.5.2 Mylan Business Overview
  7.5.3 Mylan Bendamustine Major Product Offerings
  7.5.4 Mylan Bendamustine Sales and Revenue in Global (2017-2022)
  7.5.5 Mylan Key News
7.6 Natco Pharma
  7.6.1 Natco Pharma Corporate Summary
  7.6.2 Natco Pharma Business Overview
  7.6.3 Natco Pharma Bendamustine Major Product Offerings
  7.6.4 Natco Pharma Bendamustine Sales and Revenue in Global (2017-2022)
  7.6.5 Natco Pharma Key News
7.7 Emcure
  7.7.1 Emcure Corporate Summary
  7.7.2 Emcure Business Overview
  7.7.3 Emcure Bendamustine Major Product Offerings
  7.7.4 Emcure Bendamustine Sales and Revenue in Global (2017-2022)
  7.7.5 Emcure Key News
7.8 Miracalus Pharma
  7.8.1 Miracalus Pharma Corporate Summary
  7.8.2 Miracalus Pharma Business Overview
  7.8.3 Miracalus Pharma Bendamustine Major Product Offerings
  7.8.4 Miracalus Pharma Bendamustine Sales and Revenue in Global (2017-2022)
  7.8.5 Miracalus Pharma Key News

8 GLOBAL BENDAMUSTINE PRODUCTION CAPACITY, ANALYSIS

8.1 Global Bendamustine Production Capacity, 2017-2028
8.2 Bendamustine Production Capacity of Key Manufacturers in Global Market
8.3 Global Bendamustine Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 BENDAMUSTINE SUPPLY CHAIN ANALYSIS

10.1 Bendamustine Industry Value Chain
10.2 Bendamustine Upstream Market
10.3 Bendamustine Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Bendamustine Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Bendamustine in Global Market
Table 2. Top Bendamustine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Bendamustine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Bendamustine Revenue Share by Companies, 2017-2022
Table 5. Global Bendamustine Sales by Companies, (K Units), 2017-2022
Table 6. Global Bendamustine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Bendamustine Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Bendamustine Product Type
Table 9. List of Global Tier 1 Bendamustine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bendamustine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Bendamustine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Bendamustine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Bendamustine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Bendamustine Sales (K Units), 2017-2022
Table 15. By Type - Global Bendamustine Sales (K Units), 2023-2028
Table 16. By Application – Global Bendamustine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Bendamustine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Bendamustine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Bendamustine Sales (K Units), 2017-2022
Table 20. By Application - Global Bendamustine Sales (K Units), 2023-2028
Table 21. By Region – Global Bendamustine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Bendamustine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Bendamustine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Bendamustine Sales (K Units), 2017-2022
Table 25. By Region - Global Bendamustine Sales (K Units), 2023-2028
Table 26. By Country - North America Bendamustine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Bendamustine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Bendamustine Sales, (K Units), 2017-2022
Table 29. By Country - North America Bendamustine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Bendamustine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Bendamustine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Bendamustine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Bendamustine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Bendamustine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Bendamustine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Bendamustine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Bendamustine Sales, (K Units), 2023-2028
Table 38. By Country - South America Bendamustine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Bendamustine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Bendamustine Sales, (K Units), 2017-2022
Table 41. By Country - South America Bendamustine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Bendamustine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Bendamustine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Bendamustine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Bendamustine Sales, (K Units), 2023-2028
Table 46. Teva Corporate Summary
Table 47. Teva Bendamustine Product Offerings
Table 48. Teva Bendamustine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Eisai Corporate Summary
Table 50. Eisai Bendamustine Product Offerings
Table 51. Eisai Bendamustine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Eagle Pharmaceuticals Corporate Summary
Table 53. Eagle Pharmaceuticals Bendamustine Product Offerings
Table 54. Eagle Pharmaceuticals Bendamustine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. MundiPharma Corporate Summary
Table 56. MundiPharma Bendamustine Product Offerings
Table 57. MundiPharma Bendamustine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Mylan Corporate Summary
Table 59. Mylan Bendamustine Product Offerings
Table 60. Mylan Bendamustine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Natco Pharma Corporate Summary
Table 62. Natco Pharma Bendamustine Product Offerings
Table 63. Natco Pharma Bendamustine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Emcure Corporate Summary
Table 65. Emcure Bendamustine Product Offerings
Table 66. Emcure Bendamustine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Miracalus Pharma Corporate Summary
Table 68. Miracalus Pharma Bendamustine Product Offerings
Table 69. Miracalus Pharma Bendamustine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Bendamustine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 71. Global Bendamustine Capacity Market Share of Key Manufacturers, 2020-2022
Table 72. Global Bendamustine Production by Region, 2017-2022 (K Units)
Table 73. Global Bendamustine Production by Region, 2023-2028 (K Units)
Table 74. Bendamustine Market Opportunities & Trends in Global Market
Table 75. Bendamustine Market Drivers in Global Market
Table 76. Bendamustine Market Restraints in Global Market
Table 77. Bendamustine Raw Materials
Table 78. Bendamustine Raw Materials Suppliers in Global Market
Table 79. Typical Bendamustine Downstream
Table 80. Bendamustine Downstream Clients in Global Market
Table 81. Bendamustine Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Bendamustine Segment by Type
Figure 2. Bendamustine Segment by Application
Figure 3. Global Bendamustine Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Bendamustine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Bendamustine Revenue, 2017-2028 (US$, Mn)
Figure 7. Bendamustine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Bendamustine Revenue in 2021
Figure 9. By Type - Global Bendamustine Sales Market Share, 2017-2028
Figure 10. By Type - Global Bendamustine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Bendamustine Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Bendamustine Sales Market Share, 2017-2028
Figure 13. By Application - Global Bendamustine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Bendamustine Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Bendamustine Sales Market Share, 2017-2028
Figure 16. By Region - Global Bendamustine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Bendamustine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Bendamustine Sales Market Share, 2017-2028
Figure 19. US Bendamustine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Bendamustine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Bendamustine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Bendamustine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Bendamustine Sales Market Share, 2017-2028
Figure 24. Germany Bendamustine Revenue, (US$, Mn), 2017-2028
Figure 25. France Bendamustine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Bendamustine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Bendamustine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Bendamustine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Bendamustine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Bendamustine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Bendamustine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Bendamustine Sales Market Share, 2017-2028
Figure 33. China Bendamustine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Bendamustine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Bendamustine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Bendamustine Revenue, (US$, Mn), 2017-2028
Figure 37. India Bendamustine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Bendamustine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Bendamustine Sales Market Share, 2017-2028
Figure 40. Brazil Bendamustine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Bendamustine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Bendamustine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Bendamustine Sales Market Share, 2017-2028
Figure 44. Turkey Bendamustine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Bendamustine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Bendamustine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Bendamustine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Bendamustine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Bendamustine by Region, 2020 VS 2027
Figure 50. Bendamustine Industry Value Chain
Figure 51. Marketing Channels